Physician profile
Emanuel E Gottenger
NPI 1043261548
$12,957.33
in general payments reported to CMS, 2019-2025
49 companies · $1,533 in 2025
The $1,533 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,922 · 2020: $912 · 2021: $2,653 · 2022: $3,096 · 2023: $1,602 · 2024: $1,239 · 2025: $1,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.46 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,006.13 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $1,820.74 | 2019-2025 | Myrbetriq, Xtandi |
| Axonics, INC. | $1,143.47 | 2021-2023 | Axonics |
| Boston Scientific Corporation | $1,078.48 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Ams 700 |
| Dendreon Pharmaceuticals LLC | $578.94 | 2019-2024 | Provenge |
| Abbvie INC. | $578.27 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $542.07 | 2019-2022 | |
| Pfizer INC. | $490.29 | 2019-2025 | |
| Blue Earth Diagnostics | $423.56 | 2019-2025 | Posluma |
| Janssen Biotech, INC. | $363.36 | 2019-2025 | Erleada |
| Olympus America INC. | $344.15 | 2019-2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $315.56 | 2019-2022 | |
| Coloplast Corp | $280.94 | 2019-2025 | Speedicath |
| Laborie Medical Technologies Corp. | $237.14 | 2019-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Sumitomo Pharma America, INC. | $228.73 | 2023-2025 | Orgovyx, Gemtesa |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $226.53 | 2021-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals Lp | $193.13 | 2021-2024 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $172.42 | 2019-2023 | |
| Tolmar, INC. | $163.49 | 2023-2025 | Jatenzo, Eligard |
| Myriad Genetic Laboratories, INC. | $161.45 | 2021-2025 | Prolaris |
| Becton, Dickinson and Company | $161.26 | 2023-2025 | Magic3 Go Intermittent Urinary Catheter, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire, Bard Urinary Drainage Bag |
| Terumo Medical Corporation | $142.42 | 2022 | |
| Endo USA, INC. | $140.83 | 2024-2025 | Xiaflex |
| Amgen INC. | $131.29 | 2019-2021 | |
| Antares Pharma, INC. | $131.25 | 2019-2024 | Xyosted |
| Davol INC. | $104.13 | 2022 | |
| Rochester Medical Corporation | $97.69 | 2019 | |
| Accord Healthcare, INC. | $83.06 | 2022-2025 | |
| Convatec INC. | $65.69 | 2019-2021 | |
| Medtronic, INC. | $58.08 | 2024-2025 | Interstim, Altaviva |
| Edap Technomed INC | $50.04 | 2025 | |
| Calyxo, INC. | $46.12 | 2025 | Cvac Aspiration System |
| Halozyme INC | $39.97 | 2023 | |
| Ambu INC. | $33.00 | 2021-2024 | |
| Progenics Pharmaceuticals, INC. | $26.01 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.93 | 2022 | |
| 180 Medical, INC. | $24.89 | 2021 | |
| Metuchen Pharmaceuticals | $24.79 | 2021 | |
| Myovant Sciences INC. | $24.49 | 2022 | |
| Janssen Pharmaceuticals, INC | $23.69 | 2020 | |
| Ferring Pharmaceuticals INC. | $23.33 | 2024 | Adstiladrin |
| Clarus Therapeutics INC. | $22.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $22.54 | 2023 | |
| Urovant Sciences INC | $20.43 | 2022 | |
| Acerus Pharmaceuticals Corporation | $19.30 | 2022 | |
| Teleflex LLC | $17.92 | 2024 | Urolift |
| Valencia Technologies Corporation | $17.83 | 2025 | Ecoin Device Kit |
| Telix Pharmaceuticals | $15.57 | 2025 | Illuccix |
| Allergan, INC. | $15.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emanuel Gottenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.